Middle East respiratory syndrome coronavirus (MERS-CoV): What lessons can we learn?

Journal of Hospital Infection

Volumn 91, Issue 3, 2015, Pages 188-196

  Omrani, A S ^a   Shalhoub, S ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBAVIRIN;

CLINICAL DECISION MAKING; COMMUNITY ACQUIRED PNEUMONIA; CONTACT EXAMINATION; CORONAVIRUS INFECTION; CROWDING (AREA); DELAYED DIAGNOSIS; DIARRHEA; DROMEDARY; EPIDEMIC; HEADACHE; HEALTH CARE ASSOCIATED PNEUMONIA; HUMAN; IMPORT DISEASE; INFECTION CONTROL; INFECTION PREVENTION; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; MULTIPLE ORGAN FAILURE; MYALGIA; NONHUMAN; OCCUPATIONAL EXPOSURE; PROGNOSIS; PROTOCOL COMPLIANCE; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; SEROPREVALENCE; SHORT SURVEY; SOCIAL MEDIA; TRAVEL; VIRUS TRANSMISSION; VOMITING; ZOONOSIS; ANIMAL; CAMEL; CORONAVIRUS INFECTIONS; CROSS INFECTION; DISEASE TRANSMISSION; HEALTH; ISOLATION AND PURIFICATION; PATHOLOGY; PROCEDURES; TRANSMISSION; ZOONOSES;

ANIMALS; CAMELS; CORONAVIRUS INFECTIONS; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; GLOBAL HEALTH; HUMANS; INFECTION CONTROL; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; ZOONOSES;

EID: 84945254696     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2015.08.002     Document Type: Short Survey

References (121)

1. World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV); Summary of current situation, literature update and risk assessment 7 July 2015 2015, WHO, Geneva, Available at:, [last accessed August 2015]. http://apps.who.int/iris/bitstream/10665/179184/2/WHO_MERS_RA_15.1_eng.pdf?ua=1.
2. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D.M.E., Fouchier R.A.M. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Eng J Med 2012, 367:1814-1820.
3. van Boheemen S., de Graaf M., Lauber C., et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 2012, 3:e00473-00412.
4. ProMED-mail Novel coronavirus - Saudi Arabia: human isolate. Archive Number: 20120920.1302733; 20 September 2012 21:51:30 CEST 2012, International Society for Infectious Diseases, Washington DC, Available at:, [last accessed August 2015]. http://www.promedmail.org/direct.php?id=20120920.1302733.
5. Bermingham A., Chand M.A., Brown C.S., et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill 2012, 17:20290.
6. Albarrak A.M., Stephens G.M., Hewson R., Memish Z.A. Recovery from severe novel coronavirus infection. Saudi Med J 2012, 33:1265-1269.
7. European Centre for Disease Prevention and Control Communicable Disease Threats Report, Week 18, 29 April-5 May 2012. Severe respiratory disease of unknown origin - Jordan - outbreak in ICU 2012, ECDC, Stockholm, Available at:, online version 4 May 2012 [last accessed August 2015]. http://www.ecdc.europa.eu/en/publications/Publications/CDTR.pdf.
8. Hijawi B., Abdallat M., Sayaydeh A., et al. Novel coronavirus infections in Jordan, April 2012. East Mediterr Health J 2013, 19:S12-18.
9. Al-Abdallat M.M., Payne D.C., Alqasrawi S., et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis 2014, 59:1225-1233.
10. de Groot R.J., Baker S.C., Baric R.S., et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 2013, 87:7790-7792.
11. Drosten C., Seilmaier M., Corman V.M., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013, 13:745-751.
12. Muller M.A., Meyer B., Corman V.M., et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 2015, 15:559-564.
13. Memish Z.A., Zumla A.I., Al-Hakeem R.F., Al-Rabeeah A.A., Stephens G.M. Family cluster of Middle East respiratory syndrome coronavirus infections. N Eng J Med 2013, 368:2487-2494.
14. Omrani A.S., Matin M.A., Haddad Q., Al-Nakhli D., Memish Z.A., Albarrak A.M. A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognised asymptomatic or mild case. Int J Infect Dis 2013, 17:e668-672.
15. Oboho I.K., Tomczyk S.M., Al-Asmari A.M., et al. 2014 MERS-CoV outbreak in Jeddah - a link to health care facilities. N Engl J Med 2015, 372:846-854.
16. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013, 13:752-761.
17. Saad M., Omrani A.S., Baig K., et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 2014, 29:301-306.
18. Al-Hameed F., Wahla A.S., Siddiqui S., et al. Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia. J Intensive Care Med 2015, 10.1177/0885066615579858.
19. Arabi Y.M., Arifi A.A., Balkhy H.H., et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Int Med 2014, 160:389-397.
20. Assiri A., McGeer A., Perl T.M., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Eng J Med 2013, 369:407-416.
21. Omrani A.S., Saad M.M., Baig K., et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 2014, 14:1090-1095.
22. Shalhoub S., Farahat F., Al-Jiffri A., et al. IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother 2015, 70:2129-2132.
23. Khuri-Bulos N., Payne D.C., Lu X., et al. Middle East respiratory syndrome coronavirus not detected in children hospitalised with acute respiratory illness in Amman, Jordan, March 2010 to September 2012. Clin Microbiol Infect 2013, 20:678-682.
24. Memish Z.A., Al-Tawfiq J.A., Assiri A., et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J 2014, 33:904-906.
25. Omrani A.S., Memish Z.A. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV) infection: how close are we?. Curr Treat Options Infect Dis 2015, 1-15. 10.1007/s40506-015-0048-2.
26. Falzarano D., de Wit E., Rasmussen A.L., et al. Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nature Med 2013, 19:1313-1317.
27. World Health Organization Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected; interim guidance updated 2 July 2015 2015, WHO, Geneva, Available at:, [last accessed August 2015]. http://apps.who.int/iris/bitstream/10665/178529/1/WHO_MERS_Clinical_15.1_eng.pdf?ua=1.
28. Corman V.M., Muller M.A., Costabel U., et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012, 17:20334.
29. Memish Z.A., Al-Tawfiq J.A., Makhdoom H.Q., et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis 2014, 210:1590-1594.
30. Guery B., Poissy J., el Mansouf L., et al. Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet 2013, 381:2265-2272.
31. Memish Z.A., Assiri A.M., Al-Tawfiq J.A. Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications. Int J Infect Dis 2014, 29:307-308.
32. Faure E., Poissy J., Goffard A., et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?. PloS One 2014, 9:e88716.
33. van Doremalen N., Bushmaker T., Munster V.J. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill 2013, 18:20590.
34. Memish Z.A., Cotten M., Watson S.J., et al. Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. Int J Infect Dis 2014, 23:63-68.
35. Park H.Y., Lee E.J., Ryu Y.W., et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill 2015, 20:21169.
36. Lee S.S., Wong N.S. Probable transmission chains of MERS-CoV and the multiple generations of secondary infections in South Korea. Int J Infect Dis 2015, 10.1016/j.ijid.2015.07.014.
37. Drosten C., Meyer B., Muller M.A., et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med 2014, 371:828-835.
38. Memish Z.A., Al-Tawfiq J.A., Makhdoom H.Q., et al. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect 2014, 20:469-474.
39. Pebody R.G., Chand M.A., Thomas H.L., et al. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill 2012, 17:20292.
40. Parry-Ford F., Boddington N., Pebody R., Phin N. Public health response to two incidents of confirmed MERS-CoV cases travelling on flights through London Heathrow Airport in 2014 - lessons learnt. Euro Surveill 2015, 20:21114.
41. Reuss A., Litterst A., Drosten C., et al. Contact investigation for imported case of Middle East respiratory syndrome, Germany. Emerg Infect Dis 2014, 20:620-625.
42. Buchholz U., Muller M.A., Nitsche A., et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill 2013, 18:20406.
43. Mailles A., Blanckaert K., Chaud P., et al. First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill 2013, 18:20502.
44. Tsiodras S., Baka A., Mentis A., et al. A case of imported Middle East respiratory syndrome coronavirus infection and public health response, Greece, April 2014. Euro Surveill 2014, 19:20782.
45. Kraaij-Dirkzwager M., Timen A., Dirksen K., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill 2014, 19:20817.
46. Breakwell L., Pringle K., Chea N., et al. Lack of transmission among close contacts of patient with case of Middle East respiratory syndrome imported into the United States, 2014. Emerg Infect Dis 2015, 21:1128-1134.
47. Cotten M., Watson S.J., Zumla A.I., et al. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. mBio 2014, 5:e01062-01013.
48. Drosten C., Muth D., Corman V.M., et al. An observational, laboratory-based study of outbreaks of Middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014. Clin Infect Dis 2015, 60:369-377.
49. Breban R., Riou J., Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013, 382:694-699.
50. Cauchemez S., Fraser C., Van Kerkhove M.D., et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 2014, 14:50-56.
51. World Health Organization Infection prevention and control during health care for probable or confirmed cases of novel coronavirus (nCoV) infection; interim guidance 2013, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/disease/coronavirus_infections/IPCnCoVguidance:06May13.pdf.
52. Ministry of Health, Saudi Arabia Infection prevention/control and management guidelines for patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection 2014, Ministry of Health, Saudi Arabia, Riyadh, Available at:, [last accessed August 2015]. http://www.moh.gov.sa/en/CCC/StaffRegulations/Corona/Documents/GuidelinesforCoronaPatients.pdf, 2nd ed.
53. Madani T.A., Althaqafi A.O., Alraddadi B.M. Infection prevention and control guidelines for patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Saudi Med J 2014, 35:897-913.
54. World Health Organization Case definition for case finding severe respiratory disease associated with novel coronavirus. Interim case definition as of 25 September 2012 2012, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/disease/coronavirus_infections/case_definition_25_09_2012/en/.
55. World Health Organization Revised interim case definition - novel coronavirus. Interim case definition as of 16 January 2013 2013, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/disease/coronavirus_infections/case_definition_16_01_2013/en/.
56. World Health Organization Revised interim case definition for reporting to WHO - Middle East respiratory syndrome coronavirus (MERS-CoV). Interim case definition as of 19 February 2013 2013, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/disease/coronavirus_infections/case_definition_19_02_2013/en/.
57. World Health Organization Revised interim case definition for reporting to WHO - Middle East respiratory syndrome coronavirus (MERS-CoV). Interim case definition as of 3 July 2013 2013, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/don/03-july-2015-mers-saudi-arabia/en/.
58. Al-Gethamy M., Corman V.M., Hussain R., Al-Tawfiq J.A., Drosten C., Memish Z.A. A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker. Clin Infect Dis 2015, 60:973-974.
59. Shalhoub S., AlZahrani A., Simhairi R., Mushtaq A. Successful recovery of MERS-CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report. J Clin Virol 2015, 62:69-71.
60. Madani T.A. Case definition and management of patients with MERS coronavirus in Saudi Arabia. Lancet Infect Dis 2014, 14:911-913.
61. World Health Organization Investigation of cases of human infection with Middle East respiratory syndrome coronavirus (MERS-CoV); interim guidance updated 3 July 2015 2015, WHO, Geneva, Available at:, [last accessed August 2015]. http://apps.who.int/iris/bitstream/10665/178252/1/WHO_MERS_SUR_15.2_eng.pdf?ua=1.
62. Drexler J.F., Corman V.M., Drosten C. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res 2014, 101:45-56.
63. Lelli D., Papetti A., Sabelli C., Rosti E., Moreno A., Boniotti M.B. Detection of coronaviruses in bats of various species in Italy. Viruses 2013, 5:2679-2689.
64. Memish Z.A., Mishra N., Olival K.J., et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 2013, 19:1819-1823.
65. Ithete N.L., Stoffberg S., Corman V.M., et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis 2013, 19:1697-1699.
66. Corman V.M., Ithete N.L., Richards L.R., et al. Rooting the phylogenetic tree of MERS-Coronavirus by characterization of a conspecific virus from an African Bat. J Virol 2014, 88:11297-11303.
67. Reusken C.B., Haagmans B.L., Muller M.A., et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 2013, 13:859-866.
68. Hemida M.G., Perera R.A., Wang P., et al. Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill 2013, 18:20659.
69. Reusken C.B., Ababneh M., Raj V.S., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill 2013, 18:20662.
70. Reusken C.B., Messadi L., Feyisa A., et al. Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis 2014, 20:1370-1374.
71. Alexandersen S., Kobinger G.P., Soule G., Wernery U. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound Emerg Dis 2014, 61:105-108.
72. Nowotny N., Kolodziejek J. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill 2014, 19:20781.
73. Corman V.M., Jores J., Meyer B., et al. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis 2014, 20:1319-1322.
74. Alagaili A.N., Briese T., Mishra N., et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio 2014, 5:e00884-00814.
75. Hemida M.G., Perera R.A., Al Jassim R.A., et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill 2014, 19:20828.
76. Hemida M.G., Chu D.K., Poon L.L., et al. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis 2014, 20:1231-1234.
77. Chu D.K., Poon L.L., Gomaa M.M., et al. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis 2014, 20:1049-1053.
78. Raj V.S., Farag E.A., Reusken C.B., et al. Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg Infect Dis 2014, 20:1339-1342.
79. Khalafalla A.I., Lu X., Al-Mubarak A.I., Dalab A.H., Al-Busadah K.A., Erdman D.D. MERS-CoV in upper respiratory tract and lungs of dromedary camels, Saudi Arabia, 2013-2014. Emerg Infect Dis 2015, 21:1153-1158.
80. Haagmans B.L., Al Dhahiry S.H., Reusken C.B., et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 2014, 14:140-145.
81. Memish Z.A., Cotten M., Meyer B., et al. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis 2014, 20:1012-1015.
82. Wernery U., Corman V.M., Wong E.Y., et al. Acute Middle East respiratory syndrome coronavirus infection in livestock dromedaries, Dubai, 2014. Emerg Infect Dis 2015, 21:1019-1022.
83. Chan R.W., Hemida M.G., Kayali G., et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Resp Med 2014, 2:813-822.
84. Adney D.R., van Doremalen N., Brown V.R., et al. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis 2014, 20:1999-2005.
85. Madani T.A., Azhar E.I., Hashem A.M. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 2014, 371:1360.
86. Reusken C.B., Farag E.A., Haagmans B.L., et al. Occupational exposure to dromedaries and risk for MERS-CoV infection, Qatar, 2013-2014. Emerg Infect Dis 2015, 21:1422-1425.
87. Hemida M.G., Al-Naeem A., Perera R.A., Chin A.W., Poon L.L., Peiris M. Lack of Middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis 2015, 21:699-701.
88. Aburizaiza A.S., Mattes F.M., Azhar E.I., et al. Investigation of anti-Middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis 2014, 209:243-246.
89. Memish Z.A., Alsahly A., Masri M.A., et al. Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012. Influenza Other Respir Viruses 2015, 9:64-67.
90. World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV) - Thailand. Disease Outbreak News 20 June 2015 2015, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/don/20-june-2015-mers-thailand/en/.
91. World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV) - Austria 2014, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/don/02-october-2014-mers-austria/en/.
92. Kapoor M., Pringle K., Kumar A., et al. Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States. Clin Infect Dis 2014, 59:1511-1518.
93. World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV) - The Philippines 2015, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/don/13-february-2015-mers/en/.
94. Puzelli S., Azzi A., Santini M.G., et al. Investigation of an imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. Euro Surveill 2013, 18(34).
95. Abroug F., Slim A., Ouanes-Besbes L., et al. Family cluster of Middle East respiratory syndrome coronavirus infections, Tunisia, 2013. Emerg Infect Dis 2014, 20:1527-1530.
96. Premila Devi J., Noraini W., Norhayati R., et al. Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro Surveill 2014, 19:20797.
97. Health Protection Agency UK Novel Coronavirus Investigation Team Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill 2013, 18:20427.
98. Gardner L.M., Rey D., Heywood A.E., et al. A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the Hajj. Risk Anal 2014, 34:1391-1400.
99. Gautret P. Middle East respiratory syndrome (MERS) coronavirus. What travel health advice should be given to Hajj pilgrims?. Travel Med Infect Dis 2013, 11:263-265.
100. Gautret P., Benkouiten S., Salaheddine I., Parola P., Brouqui P. Preventive measures against MERS-CoV for Hajj pilgrims. Lancet Infect Dis 2013, 13:829-831.
101. Zumla A., Mwaba P., Bates M., Al-Tawfiq J.A., Maeurer M., Memish Z.A. The Hajj pilgrimage and surveillance for Middle East respiratory syndrome coronavirus in pilgrims from African countries. Trop Med Int Health 2014, 19:838-840.
102. Khan K., Sears J., Hu V.W., et al. Potential for the international spread of Middle East respiratory syndrome in association with mass gatherings in Saudi Arabia. PLoS Curr 2013, 5. 10.1371/currents.outbreaks.a7b70897ac2fa4f79b59f90d24c860b8.
103. Gautret P., Charrel R., Belhouchat K., et al. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect 2013, 19:e315-317.
104. Gautret P., Charrel R., Benkouiten S., et al. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis 2014, 20:726-728.
105. Memish Z.A., Assiri A., Almasri M., et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis 2014, 210:1067-1072.
106. Raoult D., Charrel R., Gautret P., Parola P. From the Hajj: it's the flu, idiot. Clin Microbiol Infect 2014, 20:O1.
107. Annan A., Owusu M., Marfo K.S., et al. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health 2015, 20:807-812.
108. Benkouiten S., Charrel R., Belhouchat K., et al. Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis 2013, 57:992-1000.
109. ProMED-mail MERS-CoV (100): Saudi Arabia, South Korea. Archive Number: 20150804.3558326. 04-08-2015 21:27:59 2015, International Society for Infectious Diseases, Washington DC, Available at:, [last accessed August 2015]. http://www.promedmail.org/direct.php?id=3558326.
110. Cowling B.J., Park M., Fang V.J., Wu P., Leung G.M., Wu J.T. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill 2015, 20:21163.
111. Khan A., Farooqui A., Guan Y., Kelvin D.J. Lessons to learn from MERS-CoV outbreak in South Korea. J Infect Dev Ctries 2015, 9:543-546.
112. Hui D.S., Perlman S., Zumla A. Spread of MERS to South Korea and China. Lancet Resp Med 2015, 3:509-510.
113. Ministry of Health and Welfare (MOHW) and Korean Centers for Disease Control and Prevention (KCDC) List of hospitals with known MERS exposure; 22 June 2015 2015, MOHW and KCDC, Seoul, Available at:, [last accessed August 2015]. http://cdc.go.kr/CDC/info/CdcKrHealth0298.jsp?menuIds=HOME001-MNU1132-MNU1013&fid=5767&q_type=&q_value=&cid=63640&pageNum.
114. World Health Organization Preliminary data from sequencing of viruses in the Republic of Korea and the People's Republic of China. MERS-CoV situation assessment 9 June 2015 2015, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/csr/disease/coronavirus_infections/mers-situation-assessment09-06.pdf?ua=1.
115. World Health Organization Managing contacts in the MERS-CoV outbreak in the Republic of Korea; briefing notes on MERS-CoV 1 July 2015 2015, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/mediacentre/news/mers/briefing-notes/update-1-july-2015/en/.
116. World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV): Summary and risk assessment of current situation in the Republic of Korea and China - as of 19 June 2015 2015, WHO, Geneva, Available at:, [last accessed August 2015]. http://www.who.int/emergencies/mers-cov/mers-cov-republic-of-korea-and-china-risk-assessment-19-june-2015.pdf?ua=1.
117. Korean Society of Infectious Diseases Korean Society for Healthcare-associated Infection Control and Prevention. An unexpected outbreak of Middle East Respiratory syndrome coronavirus infection in the Republic of Korea, 2015. Infect Chemother 2015, 47:120-122.
118. George D.R., Rovniak L.S., Kraschnewski J.L. Dangers and opportunities for social media in medicine. Clin Obstet Gynecol 2013, 56:453-462.
119. Ventola C.L. Social media and health care professionals: benefits, risks, and best practices. Pharm Therapeut (P T) 2014, 39:491-520.
120. Chretien K.C., Kind T. Social media and clinical care: ethical, professional, and social implications. Circulation 2013, 127:1413-1421.
121. Mackay I.M., Arden K.E. Middle East respiratory syndrome: an emerging coronavirus infection tracked by the crowd. Virus Res 2015, 202:60-88.